Virus News and Research

Latest Virus News and Research

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Researchers at the University of Kent in the UK and the Hannover Medical School and Goethe University in Germany have observed that the protease inhibitor aprotinin can inhibit viral replication by preventing SARS-CoV-2 entry into host cells.

24 Nov 2020

Technology used for screening liquids can be adapted to provide rapid COVID-19 testing

Loughborough University researchers are hoping a technology they developed to quickly screen liquids for microorganisms can be adapted to provide rapid testing for Covid-19.

24 Nov 2020

SARS-CoV-2's RNA folding structures are potential therapeutic targets, study finds

A team of researchers at Goethe University in Germany has observed the RNA folding structures of the SARS-CoV-2 genome that aids the infection process.

24 Nov 2020

Researchers recommend antibody cocktail to tackle SARS-CoV-2 mutations

A new study released on the medRxiv* preprint server indicates that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic – is developing multiple mutations that affect neutralization by antibodies.

24 Nov 2020

New A.I. is fast and accurate at detecting COVID-19 from chest X-rays

Researchers have innovated a platform that uses A.I. to detect COVID-19 at higher levels of accuracy than specialized thoracic radiologists.

24 Nov 2020

Biosensor assay SARS-CoV-2 antibody test may predict COVID-19 severity in patients

Researchers in New York, USA, have found an association of mortality with an early humoral response to SARS-CoV-2 infection within the first few days after onset of symptoms (DAOS), using a highly sensitive and automated testing-on-a-probe (TOP) biosensor assays for SARS-CoV-2.

24 Nov 2020

New therapy developed for flu infections may also prove effective against HIV, COVID-19

A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.

24 Nov 2020

Avacta Group announces significant progress in the development of SARS-CoV-2 rapid antigen test

Avacta Group plc, the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, is pleased to announce significant progress in the development of a highly scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test being carried out with BBI Solutions, and that the lateral flow test has very good analytical sensitivity with laboratory samples.

From Avacta Life Sciences Ltd. 24 Nov 2020

Research links SARS-CoV-2 prevalence, hospital surfaces and patient microbiomes

Researchers found a higher bacterial diversity in SARS-CoV-2 patient rooms and surfaces in the room, suggesting bacterial diversity may play a role in virus transmission.

24 Nov 2020

Study sheds new light on impact of COVID-19 in pediatric population

In the most comprehensive analysis to date of U.S. children tested and treated for COVID-19, an organization representing seven of the nation's largest pediatric medical centers reports that some groups of children are faring significantly worse than children in general during the pandemic.

24 Nov 2020

Mauritian Prime Minister calls upon world leaders to ensure fair distribution of Covid-19 vaccines

Mauritian Prime Minister Pravind Jugnauth calls for Covid-19 vaccines to be ‘distributed fairly’ amid fears that some parts of the world might be left behind in the dash for coronavirus immunity.

24 Nov 2020

Research provides key information on transmission, development of mutations in SARS-CoV-2 virus

In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.

24 Nov 2020

COVID-19 study underscores the importance of protection guidelines based on fluid dynamics research

Researchers who study the physics of fluids are learning why certain situations increase the risk that droplets will transmit diseases like COVID-19.

24 Nov 2020

New zinc oxide surface kills airborne viruses and bacteria

They burst out of toilet bubbles, swim across drinking water, spread through coughs. Tiny infectious microbes--from the virus that causes COVID-19 to waterborne bacteria--kill millions of people around the world each year.

24 Nov 2020

SARS-CoV-2 RNA best preserved in wastewater under freezing conditions

Wastewater surveillance has been reported to be a feasible and efficient way to monitor the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the current COVID-19 pandemic. A recent study draws attention to the need to freeze wastewater samples if the analysis is carried out later rather than immediately.

24 Nov 2020

Study: Aprotinin can inhibit virus replication by preventing SARS-CoV2 entry into host cells

The surface of the SARS-CoV-2 virus is studded with spike proteins. The virus needs these in order to dock onto proteins (ACE2 receptors) on the surface of the host cell.

24 Nov 2020

COVID-19: HLA class I genotypes and mortality

The study, published on the preprint server medRxiv, explores the ability of HLA class I molecules to mediate the outcome in COVID-19 patients.

24 Nov 2020

Researchers conduct aerosol characterization experiments to protect healthcare workers from COVID-19

The rapid spread of COVID-19 overwhelmed hospitals that were unable to contend with the increasing number of patients, many requiring ventilators and other critical care. Such conditions can put medical workers at risk. Now researchers are studying methods to increase hospital safety and efficacy during the pandemic.

24 Nov 2020

Early high-titer convalescent plasma prevents 75% of severe COVID-19 in elderly

A promising new clinical study published on the preprint server medRxiv reports that if convalescent plasma with a high titer of antibodies is given early in the course of COVID-19 in elderly patients, the risk of severe illness is reduced by 73%.

24 Nov 2020

COVID-19 severity is higher in male cancer patients compared to females

Men with cancer and COVID-19 may be at significantly higher risk for severe symptoms and even death as compared to females fighting both, a University of Kansas Cancer Center research team has found.

23 Nov 2020

Virus News and Research

Latest Virus News and Research

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Technology used for screening liquids can be adapted to provide rapid COVID-19 testing

SARS-CoV-2's RNA folding structures are potential therapeutic targets, study finds

Researchers recommend antibody cocktail to tackle SARS-CoV-2 mutations

New A.I. is fast and accurate at detecting COVID-19 from chest X-rays

Biosensor assay SARS-CoV-2 antibody test may predict COVID-19 severity in patients

New therapy developed for flu infections may also prove effective against HIV, COVID-19

Avacta Group announces significant progress in the development of SARS-CoV-2 rapid antigen test

Research links SARS-CoV-2 prevalence, hospital surfaces and patient microbiomes

Study sheds new light on impact of COVID-19 in pediatric population

Mauritian Prime Minister calls upon world leaders to ensure fair distribution of Covid-19 vaccines

Research provides key information on transmission, development of mutations in SARS-CoV-2 virus

COVID-19 study underscores the importance of protection guidelines based on fluid dynamics research

New zinc oxide surface kills airborne viruses and bacteria

SARS-CoV-2 RNA best preserved in wastewater under freezing conditions

Study: Aprotinin can inhibit virus replication by preventing SARS-CoV2 entry into host cells

COVID-19: HLA class I genotypes and mortality

Researchers conduct aerosol characterization experiments to protect healthcare workers from COVID-19

Early high-titer convalescent plasma prevents 75% of severe COVID-19 in elderly

COVID-19 severity is higher in male cancer patients compared to females

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in